Today Biogen Idec announced that Health Canada has approved ALPROLIX [Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B.

View post:
Biogen Idec’s ALPROLIX gets Health Canada approval for hemophilia B

Scroll to Top